Jan 27 (Reuters) - ‌The ​U.S. ‌Centers for ​Medicare & Medicaid ‍Services on ​Tuesday ​named a ⁠new group of branded drugs ...

Jan 27 (Reuters) - The U.S. Centers for Medicare & Medicaid Services on Tuesday named the 15 new drugs targeted for Medicare ...

Mid-stage trial data showed Roche's experimental shot delivered weight loss on par with leading obesity treatments, ...

Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA ...

Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever.

NFC North News posted a video on X alongside NFL’s Green Bay Packers’ logo. They captioned the post: “BREAKING: Following ...

The 46-year-old, whose real name is Alyssa DeFord, opened up about the experience on an episode of her podcast, where she ...

The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...

A larger percentage of GLP-1 users say social media and online research are their most trusted source for microdosing ...

Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...

Qilu Pharmaceutical has struck a deal to tap into Insilico Medicine’s artificial intellige | Qilu Pharmaceutical has struck a ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...